Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Asheville › NPI 1962987677
Transport

MH Mission Hospital, LLLP

MH Mission Hospital, LLLP was paid $62.29M by Medicaid between Feb 2019 and Dec 2024, across 449 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.

33Billing provider infoMH MISSION HOSPITAL, LLLP
ASHEVILLE, NC 28801
33aNPI1962987677assigned 09/27/2018
33bProvider typeAir Ambulance
28Total paid$62.29M
24GClaims1,031,426
24DCodes billed449
24AFirst – last monthFeb 2019 – Dec 2024
Compared with peers

Next to other Air Ambulance providers in North Carolina

Rank by total paid#1 of 11
Median peer was paid$610K
This provider vs. median102×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019209,346$9.55M
2020253,381$12.60M
2021228,995$14.51M
2022137,183$10.13M
2023129,139$9.07M
2024incomplete73,382$6.42M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 39,111 34,300 $8.15M
41899 Unlisted procedure, dentoalveolar structures 11% 6,131 4,632 $7.10M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 42,968 37,637 $6.24M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.4% 5,145 4,542 $3.34M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.3% 8,447 7,230 $2.66M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4.0% 7,627 6,807 $2.52M
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room 3.9% 984 907 $2.40M
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 3.4% 6,375 5,666 $2.10M
70450 Computed tomography, head or brain; without contrast material 2.2% 5,264 4,673 $1.35M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.6% 40,057 35,809 $973K
93320 1.5% 7,065 6,286 $924K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 21,833 19,932 $917K
437 more codes
93325 1.4% 7,311 $863K
G0378 Hospital observation service, per hour 1.3% 4,893 $802K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.1% 10,060 $706K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,196 $614K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,156 $601K
80053 Comprehensive metabolic panel <1% 68,529 $579K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 19,034 $557K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 787 $546K
85027 <1% 86,782 $513K
72125 Computed tomography, cervical spine; without contrast material <1% 1,991 $507K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,251 $500K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 634 $499K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 791 $468K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,398 $375K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 845 $375K
71046 Radiologic examination, chest; 2 views <1% 6,934 $350K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 7,204 $332K
96375 Therapeutic injection; each additional sequential IV push <1% 7,095 $321K
71045 Radiologic examination, chest; single view <1% 7,939 $321K
84443 Thyroid stimulating hormone (TSH) <1% 20,452 $316K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 8,977 $298K
81229 <1% 392 $296K
78815 Positron emission tomography (PET) for limited area imaging <1% 493 $296K
95816 <1% 1,679 $289K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,428 $278K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 5,949 $272K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 733 $269K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,987 $268K
70551 Magnetic resonance imaging, brain; without contrast material <1% 556 $242K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 8,950 $242K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,461 $238K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,468 $213K
93017 <1% 1,519 $212K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,640 $206K
74018 <1% 3,591 $199K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 520 $193K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 7,066 $188K
96376 <1% 3,407 $177K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,167 $169K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 291 $156K
93976 <1% 996 $151K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,452 $150K
99152 <1% 1,978 $148K
96361 Intravenous infusion, hydration; each additional hour <1% 7,057 $142K
99153 Mod sedat endo service >5yrs <1% 1,091 $139K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 5,355 $136K
J1453 Injection, fosaprepitant, 1 mg <1% 496 $134K
93922 <1% 3,398 $128K
64483 <1% 656 $126K
83036 Hemoglobin; glycosylated (A1C) <1% 13,119 $124K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,179 $124K
36415 Collection of venous blood by venipuncture <1% 52,130 $123K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 140 $121K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 9,789 $118K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 4,488 $118K
93880 <1% 1,445 $116K
93971 <1% 1,128 $113K
C1769 Guide wire <1% 2,588 $113K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,084 $108K
99213 Doctor's office visit, returning patient (routine) <1% 3,867 $107K
80061 Lipid panel <1% 8,148 $95K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,732 $93K
87086 Culture, bacterial; quantitative colony count, urine <1% 12,459 $92K
72081 <1% 1,099 $92K
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg <1% 42 $90K
83880 <1% 3,969 $89K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,990 $88K
59025 Fetal non-stress test <1% 3,259 $87K
72170 <1% 1,422 $83K
73610 <1% 1,739 $81K
J0897 Injection, denosumab, 1 mg <1% 112 $80K
93970 <1% 548 $79K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 3,845 $77K
93351 <1% 272 $74K
73630 <1% 1,529 $74K
80048 Basic metabolic panel (calcium, ionized) <1% 11,858 $73K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 182 $73K
84484 <1% 10,032 $71K
81001 <1% 24,884 $70K
86780 <1% 5,224 $69K
76830 Ultrasound, transvaginal <1% 781 $66K
73564 <1% 1,214 $65K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,692 $65K
70486 <1% 227 $63K
97165 <1% 2,229 $63K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 294 $62K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 674 $61K
29581 <1% 1,873 $61K
84439 <1% 6,323 $60K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 406 $58K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 758 $57K
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) <1% 616 $54K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 567 $54K
83690 <1% 9,628 $54K
73100 <1% 1,132 $53K
44970 <1% 16 $53K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,022 $52K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,912 $52K
92610 <1% 730 $51K
76770 <1% 471 $50K
J3490 Unclassified drugs <1% 10,139 $50K
73502 <1% 736 $50K
92523 <1% 1,250 $48K
73030 <1% 1,220 $48K
87070 <1% 5,314 $48K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,856 $47K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,133 $47K
73130 <1% 1,024 $47K
73090 <1% 1,142 $47K
82728 <1% 3,590 $46K
86850 <1% 4,925 $46K
88307 <1% 513 $46K
87653 <1% 1,855 $44K
84466 <1% 3,397 $44K
73110 <1% 765 $44K
96417 <1% 594 $43K
96131 <1% 882 $42K
36902 <1% 103 $41K
12001 <1% 341 $41K
77334 <1% 144 $40K
84703 <1% 5,385 $40K
97161 <1% 1,465 $40K
76642 <1% 972 $40K
87077 <1% 4,719 $40K
0240U <1% 644 $39K
87186 <1% 4,591 $39K
94010 <1% 1,436 $38K
83735 <1% 7,427 $37K
73560 <1% 860 $37K
81025 <1% 5,917 $37K
93458 <1% 15 $36K
82607 <1% 2,950 $36K
86803 <1% 2,768 $35K
73590 <1% 1,001 $35K
96367 <1% 686 $32K
86703 <1% 2,962 $32K
C1776 Joint device (implantable) <1% 20 $31K
73080 <1% 606 $31K
J2785 Injection, regadenoson, 0.1 mg <1% 459 $30K
76942 <1% 306 $30K
82784 <1% 2,274 $30K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,096 $30K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,095 $30K
97162 <1% 1,128 $29K
72100 <1% 821 $29K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 449 $28K
85610 <1% 9,309 $27K
J2323 Injection, natalizumab, 1 mg <1% 13 $27K
83605 <1% 3,339 $26K
76937 <1% 845 $26K
A0436 Rotary wing air mileage, per statute mile <1% 615 $26K
83540 <1% 3,987 $26K
86140 <1% 4,762 $25K
12011 <1% 208 $24K
99214 Doctor's office visit, returning patient (more involved) <1% 714 $23K
96112 <1% 460 $23K
73070 <1% 510 $22K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 303 $22K
10060 <1% 116 $21K
86762 <1% 1,510 $21K
87040 <1% 2,190 $21K
77073 <1% 534 $20K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 940 $20K
73552 <1% 508 $20K
87340 <1% 2,196 $20K
83516 <1% 1,436 $19K
77336 <1% 363 $19K
73140 <1% 488 $19K
88304 <1% 513 $18K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 525 $18K
96415 <1% 934 $18K
96130 <1% 908 $17K
29065 <1% 435 $17K
84702 <1% 2,141 $17K
82746 <1% 1,411 $17K
77300 <1% 97 $16K
82951 <1% 1,205 $16K
87634 <1% 801 $16K
83970 <1% 452 $16K
80050 General health panel <1% 1,398 $15K
97166 <1% 599 $15K
80074 <1% 323 $15K
87522 Neg quan hep c or qual rna <1% 492 $15K
86738 <1% 857 $15K
36430 <1% 125 $15K
84403 <1% 549 $15K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 467 $14K
85730 <1% 3,070 $13K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,102 $13K
77072 <1% 337 $13K
80164 <1% 1,059 $13K
86901 <1% 5,262 $13K
86900 <1% 5,261 $13K
77066 Tomosynthesis, mammo <1% 463 $13K
72141 <1% 32 $12K
88342 <1% 412 $12K
71250 <1% 172 $12K
85379 <1% 1,576 $11K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 207 $11K
G0379 Direct admission of patient for hospital observation care <1% 94 $11K
84146 <1% 531 $11K
87210 <1% 2,684 $11K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 544 $10K
99406 <1% 1,016 $10K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 828 $10K
86923 <1% 130 $10K
87205 <1% 2,595 $10K
83001 <1% 514 $10K
90834 Psychotherapy session, about 45 minutes <1% 617 $9K
92567 <1% 442 $9K
88341 <1% 114 $9K
90847 Family psychotherapy with the patient present, 50 minutes <1% 1,504 $9K
87449 <1% 622 $8K
82077 <1% 2,667 $8K
86038 <1% 677 $8K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 599 $8K
76818 <1% 108 $8K
87581 <1% 294 $8K
87486 <1% 294 $8K
83002 <1% 378 $8K
86304 <1% 534 $8K
82565 <1% 2,093 $8K
82670 <1% 301 $7K
87427 <1% 469 $7K
81243 <1% 183 $7K
29075 <1% 483 $7K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,901 $7K
87075 <1% 809 $7K
82140 <1% 576 $7K
72050 <1% 84 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,459 $7K
85652 <1% 2,649 $7K
88185 <1% 18 $6K
80076 <1% 910 $6K
96137 <1% 618 $6K
85651 <1% 1,702 $6K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,021 $6K
80177 <1% 467 $6K
96040 <1% 873 $6K
74230 <1% 89 $6K
12002 <1% 42 $6K
95819 <1% 43 $6K
82550 <1% 982 $6K
76870 <1% 72 $6K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 237 $6K
86364 <1% 937 $6K
84436 <1% 901 $5K
82533 <1% 285 $5K
95782 <1% 12 $5K
82330 <1% 598 $5K
84270 <1% 193 $5K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 15 $5K
77290 <1% 15 $5K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 115 $5K
87116 <1% 402 $5K
82274 <1% 274 $5K
77001 <1% 109 $4K
84100 <1% 1,274 $4K
90791 Psychiatric diagnostic evaluation <1% 185 $4K
36591 <1% 100 $4K
82043 <1% 827 $4K
84156 <1% 1,170 $4K
84305 <1% 264 $4K
84481 <1% 261 $4K
82947 <1% 1,229 $4K
82570 <1% 878 $4K
86665 <1% 148 $4K
87046 <1% 386 $4K
82247 <1% 831 $4K
82977 <1% 709 $4K
80178 <1% 574 $4K
82105 <1% 274 $4K
C1768 Graft, vascular <1% 75 $4K
97116 <1% 488 $4K
87045 <1% 383 $4K
85049 <1% 976 $4K
92579 <1% 215 $4K
73060 <1% 110 $4K
99215 Doctor's office visit, returning patient (complex) <1% 70 $4K
87102 <1% 404 $4K
96136 <1% 833 $4K
86300 <1% 96 $4K
85046 <1% 577 $4K
87641 <1% 300 $3K
80069 <1% 493 $3K
84112 <1% 52 $3K
86039 <1% 299 $3K
J2704 Injection, propofol, 10 mg <1% 2,304 $3K
96127 <1% 3,679 $3K
83655 <1% 281 $3K
71101 <1% 49 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 31 $3K
82375 <1% 356 $3K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 622 $3K
87015 <1% 376 $3K
76885 <1% 148 $3K
82677 <1% 146 $3K
86787 <1% 209 $3K
82248 <1% 913 $3K
82150 <1% 406 $3K
86376 <1% 168 $3K
74240 <1% 13 $3K
49083 <1% 26 $3K
77075 <1% 14 $2K
84153 <1% 168 $2K
87206 <1% 402 $2K
83615 <1% 444 $2K
86336 <1% 166 $2K
92611 <1% 43 $2K
86003 <1% 49 $2K
82010 <1% 292 $2K
97163 <1% 126 $2K
P9016 Red blood cells, leukocytes reduced, each unit <1% 16 $2K
87329 <1% 160 $2K
93926 <1% 65 $2K
72131 <1% 15 $2K
74019 <1% 48 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 75 $2K
81003 <1% 869 $2K
83050 <1% 354 $2K
84402 <1% 59 $2K
87147 <1% 352 $2K
87328 <1% 141 $2K
86431 <1% 324 $2K
29125 <1% 26 $2K
92228 <1% 99 $2K
76820 <1% 21 $2K
86800 <1% 90 $2K
83993 <1% 71 $2K
83021 <1% 89 $2K
86706 <1% 150 $2K
85018 <1% 904 $2K
74022 <1% 29 $2K
84450 <1% 855 $1K
72072 <1% 29 $1K
82803 <1% 108 $1K
76380 <1% 13 $1K
82024 <1% 33 $1K
88313 <1% 13 $1K
73620 <1% 44 $1K
97167 <1% 60 $1K
87640 <1% 102 $1K
84132 <1% 907 $1K
96411 <1% 60 $1K
93978 <1% 26 $1K
87081 <1% 158 $1K
84425 <1% 71 $1K
S9480 Intensive outpatient psychiatric services, per diem <1% 92 $1K
A9270 Non-covered item or service <1% 340 $999.85
87338 <1% 61 $991.98
95886 <1% 13 $982.94
82627 <1% 38 $977.36
99170 <1% 53 $968.45
76377 <1% 27 $955.32
84550 <1% 357 $937.73
96523 <1% 48 $887.01
88142 <1% 43 $877.90
88184 <1% 19 $834.86
96368 <1% 24 $828.59
92586 <1% 13 $808.51
C2617 Stent, non-coronary, temporary, without delivery system <1% 12 $774.22
86361 <1% 28 $759.07
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 105 $756.84
76825 <1% 18 $697.05
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 40 $696.12
62321 <1% 12 $693.80
G0008 Administration of influenza virus vaccine <1% 47 $625.81
80143 <1% 342 $613.77
82785 <1% 39 $581.80
77065 Tomosynthesis, mammo <1% 30 $569.78
76827 <1% 18 $535.23
81002 <1% 192 $503.86
94664 <1% 34 $484.01
73000 <1% 19 $466.51
87324 <1% 42 $438.34
83498 <1% 12 $426.36
80183 <1% 29 $379.94
83883 <1% 31 $371.64
82040 <1% 140 $365.29
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,278 $349.07
93990 <1% 16 $344.57
86258 <1% 38 $337.97
J7999 Compounded drug, not otherwise classified <1% 339 $329.07
80179 <1% 301 $326.78
85014 <1% 209 $308.50
86708 <1% 29 $293.36
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 13 $287.10
82378 <1% 14 $260.04
84165 <1% 41 $245.01
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,351 $242.31
82106 <1% 13 $241.45
82310 <1% 108 $230.67
87252 <1% 15 $223.30
83520 <1% 12 $203.28
29705 <1% 18 $194.14
J7050 Infusion, normal saline solution, 250 cc <1% 1,042 $188.80
J2060 Injection, lorazepam, 2 mg <1% 70 $180.56
82397 <1% 17 $172.80
86200 <1% 14 $148.13
J1170 Injection, hydromorphone, up to 4 mg <1% 651 $135.99
86308 <1% 26 $135.45
86880 <1% 29 $109.83
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,523 $108.97
J2270 Injection, morphine sulfate, up to 10 mg <1% 499 $99.62
84460 <1% 264 $92.41
J0690 Injection, cefazolin sodium, 500 mg <1% 840 $87.27
11719 <1% 16 $84.54
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,169 $82.93
A6253 Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing <1% 737 $73.58
88311 <1% 25 $56.52
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 126 $55.47
A9585 Injection, gadobutrol, 0.1 ml <1% 67 $53.80
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 389 $53.42
84295 <1% 73 $51.43
92587 <1% 44 $49.75
90715 <1% 14 $46.80
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 129 $43.91
95012 <1% 14 $40.70
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 13 $23.93
J1644 Injection, heparin sodium, per 1000 units <1% 313 $22.14
J3475 Injection, magnesium sulfate, per 500 mg <1% 81 $19.33
J1815 Injection, insulin, per 5 units <1% 68 $11.85
J7030 Infusion, normal saline solution , 1000 cc <1% 30 $10.14
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 99 $6.26
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 60 $6.10
A6223 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing <1% 17 $5.50
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 138 $5.34
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 16 $2.16
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 16 $1.67
J1630 Injection, haloperidol, up to 5 mg <1% 19 $1.45
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 15 $0.73
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 924 $0.00
81329 0% 56 $0.00
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 0% 28 $0.00
83631 0% 19 $0.00
C9399 Unclassified drugs or biologicals 0% 25 $0.00
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 112 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAYNES, LAURIE (CFO)